这是一篇来自已证抗体库的有关人类 CD55的综述,是根据21篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD55 抗体。
CD55 同义词: CHAPLE; CR; CROM; DAF; TC

BioLegend
小鼠 单克隆(JS11)
  • 免疫组化-冰冻切片; 小鼠; 图 9d
BioLegend CD55抗体(BioLegend, JS11)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 9d). J Exp Med (2020) ncbi
小鼠 单克隆(JS11)
  • 流式细胞仪; 人类; 1:100; 图 1d
BioLegend CD55抗体(Biolegend, 311308)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1d). elife (2020) ncbi
小鼠 单克隆(JS11)
  • 流式细胞仪; 人类
BioLegend CD55抗体(Biolegend, #311314)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(JS11)
  • 流式细胞仪; 人类
BioLegend CD55抗体(Biolegend, 311308)被用于被用于流式细胞仪在人类样本上. Exp Hematol (2014) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(MEM-118)
  • 免疫组化; 人类; 1:200; 图 3c
艾博抗(上海)贸易有限公司 CD55抗体(Abcam, ab1422)被用于被用于免疫组化在人类样本上浓度为1:200 (图 3c). Arthritis Res Ther (2020) ncbi
小鼠 单克隆(MEM-118)
  • 免疫细胞化学; 人类; 图 4d
艾博抗(上海)贸易有限公司 CD55抗体(Abcam, ab1422)被用于被用于免疫细胞化学在人类样本上 (图 4d). Oncol Lett (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(NaM16-4D3)
  • 免疫印迹; 小鼠; 图 2i
圣克鲁斯生物技术 CD55抗体(Santa Cruz Biotechnology Inc, sc-51733)被用于被用于免疫印迹在小鼠样本上 (图 2i). Cancer Res (2018) ncbi
小鼠 单克隆(H-7)
  • 免疫组化-石蜡切片; 人类
圣克鲁斯生物技术 CD55抗体(Santa Cruz Biotechnology, sc-133220)被用于被用于免疫组化-石蜡切片在人类样本上. Arch Pathol Lab Med (2014) ncbi
小鼠 单克隆(BRIC 216)
  • 抑制或激活实验; 人类; 图 6
  • 免疫印迹; 人类; 图 7b
圣克鲁斯生物技术 CD55抗体(Santa Cruz Biotechnology, BRIC 216)被用于被用于抑制或激活实验在人类样本上 (图 6) 和 被用于免疫印迹在人类样本上 (图 7b). Am J Physiol Gastrointest Liver Physiol (2014) ncbi
赛默飞世尔
小鼠 单克隆(BRIC-216)
  • 免疫细胞化学; 人类; 图 3
赛默飞世尔 CD55抗体(Thermo Fisher, MA1-91161)被用于被用于免疫细胞化学在人类样本上 (图 3). J Immunol (2016) ncbi
小鼠 单克隆(67)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD55抗体(Invitrogen, 67)被用于被用于流式细胞仪在人类样本上 (图 2). Cytometry B Clin Cytom (2010) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(67)
  • 免疫组化; 人类
伯乐(Bio-Rad)公司 CD55抗体(AbD Serotec, 67)被用于被用于免疫组化在人类样本上. Arthritis Rheumatol (2014) ncbi
LifeSpan Biosciences
小鼠 单克隆(143-30)
  • 免疫组化-石蜡切片; 人类; 图 1
LifeSpan Biosciences CD55抗体(LifeSpan, 143?C30)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Arthritis Res Ther (2015) ncbi
碧迪BD
小鼠 单克隆(IA10)
  • 流式细胞仪; 人类; 图 s4g
碧迪BD CD55抗体(BD, 561901)被用于被用于流式细胞仪在人类样本上 (图 s4g). Cell Death Differ (2019) ncbi
小鼠 单克隆(IA10)
  • 其他; 人类; 500 ug/ml; 图 1
碧迪BD CD55抗体(Becton Dickinson, 555691)被用于被用于其他在人类样本上浓度为500 ug/ml (图 1). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(IA10)
  • 免疫组化-冰冻切片; 小鼠; 1:40
  • 免疫组化-冰冻切片; 人类; 1:40; 表 3
碧迪BD CD55抗体(BD Pharmigen, 555693)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:40 和 被用于免疫组化-冰冻切片在人类样本上浓度为1:40 (表 3). J Neuroinflammation (2016) ncbi
小鼠 单克隆(IA10)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD55抗体(BD, 555694)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(IA10)
  • 流式细胞仪; 人类
碧迪BD CD55抗体(BD Pharmingen, 555696)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(IA10)
  • 免疫组化-冰冻切片; 小鼠; 图 1
碧迪BD CD55抗体(BD Pharmingen, IA10)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 1). J Virol (2015) ncbi
小鼠 单克隆(IA10)
  • 流式细胞仪; 人类
碧迪BD CD55抗体(BD, IA10)被用于被用于流式细胞仪在人类样本上. Arthritis Res Ther (2015) ncbi
小鼠 单克隆(IA10)
  • 流式细胞仪; 人类; 图 S5
碧迪BD CD55抗体(BD Biosciences, clone IA10)被用于被用于流式细胞仪在人类样本上 (图 S5). Invest Ophthalmol Vis Sci (2014) ncbi
小鼠 单克隆(IA10)
  • 流式细胞仪; 犬
碧迪BD CD55抗体(BD Pharmingen, IA10)被用于被用于流式细胞仪在犬样本上. Virol J (2012) ncbi
文章列表
  1. Kaaij M, van Tok M, Blijdorp I, Ambarus C, Stock M, Pots D, et al. Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis. J Exp Med. 2020;217: pubmed 出版商
  2. Gunesch J, Dixon A, Ebrahim T, Berrien Elliott M, Tatineni S, Kumar T, et al. CD56 regulates human NK cell cytotoxicity through Pyk2. elife. 2020;9: pubmed 出版商
  3. Trimova G, Yamagata K, Iwata S, Hirata S, Zhang T, Uemura F, et al. Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages. Arthritis Res Ther. 2020;22:24 pubmed 出版商
  4. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed 出版商
  5. Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J, et al. Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery. Cancer Res. 2018;78:798-808 pubmed 出版商
  6. Kapka Skrzypczak L, Popek S, Sawicki K, Wolinska E, Czajka M, Skrzypczak M. Effect of IL-6 and IL-8 on the expression of the complement activation inhibitors MAC-inhibitory protein and decay-accelerating factor in ovarian cancer A2780 cells. Oncol Lett. 2016;12:1507-1512 pubmed
  7. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  8. Bahia El Idrissi N, Bosch S, Ramaglia V, Aronica E, Baas F, Troost D. Complement activation at the motor end-plates in amyotrophic lateral sclerosis. J Neuroinflammation. 2016;13:72 pubmed 出版商
  9. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  10. Sartain S, Turner N, Moake J. TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells. J Immunol. 2016;196:832-45 pubmed 出版商
  11. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed 出版商
  12. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed 出版商
  13. Pan J, Zhang L, Odenwald M, Shen L, Turner J, Bergelson J. Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral route. J Virol. 2015;89:4311-8 pubmed 出版商
  14. Karpus O, Kiener H, Niederreiter B, Yilmaz Elis A, van der Kaa J, Ramaglia V, et al. CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis. Arthritis Res Ther. 2015;17:6 pubmed 出版商
  15. Dezern A, Uknis M, Yuan X, Mukhina G, VARELA J, Saye J, et al. Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria. Exp Hematol. 2014;42:857-61.e1 pubmed 出版商
  16. Shang Y, Chai N, Gu Y, Ding L, Yang Y, Zhou J, et al. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med. 2014;138:910-9 pubmed 出版商
  17. Wu Y, Wang Y, Qin F, Wang Z, Wang Y, Yang Y, et al. CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of ?-gal xenoantigen in colon tumor cells. Am J Physiol Gastrointest Liver Physiol. 2014;306:G1056-64 pubmed 出版商
  18. Yang P, Baciu P, Kerrigan B, Etheridge M, Sung E, Toimil B, et al. Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress. Invest Ophthalmol Vis Sci. 2014;55:3012-21 pubmed 出版商
  19. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed 出版商
  20. Krautkrämer E, Lehmann M, Bollinger V, Zeier M. Polar release of pathogenic Old World hantaviruses from renal tubular epithelial cells. Virol J. 2012;9:299 pubmed 出版商
  21. Borowitz M, Craig F, DiGiuseppe J, Illingworth A, Rosse W, Sutherland D, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010;78:211-30 pubmed 出版商